Watch Free Classes

Daily News Analysis » First Vaccine of Chikungunya: Ixchiq

First Vaccine of Chikungunya: Ixchiq

The world’s first chikungunya vaccine, Ixchiq, was approved by the FDA in the U.S. on November 9, 2023.

Table of Content

What is Chikungunya?

Chikungunya is a viral infection known for causing severe joint pain and fever.
It’s transmitted by Aedes aegypti and Aedes albopictus female mosquitoes.

The Chikungunya Vaccine: Ixchiq

It’s a single-dose vaccine injected into the muscle. It contains a live, weakened version of the chikungunya virus.

Significance of the Vaccine

Addresses an unmet medical need for a disease with limited treatment options.
Could accelerate vaccine rollout in countries with high chikungunya prevalence.
Represents a significant advancement in preventing a debilitating disease.

Why in News:

The world’s first chikungunya vaccine, Ixchiq, was approved by the FDA in the U.S. on November 9, 2023.